The cover story in the current issue of Chemical & Engineering News (C&EN), ACS' weekly newsmagazine, assesses the scientific foundation and clinical landscape of those amyloid-beta blockers.
C&EN Senior Editor Lisa Jarvis notes that amyloid-beta is at the heart of a central hypothesis — and simmering controversy — about Alzheimer's disease. Some scientists are convinced that amyloid-beta is the root cause of the nerve-cell death and subsequent mental decline in individuals with Alzheimer's disease.
Others think that something else, perhaps a still-unidentified environmental neurotoxin, is the real culprit. That mystery agent, they suspect, triggers formation of beta-amyloid.
Michael Bernstein | EurekAlert!
Ion treatments for cardiac arrhythmia — Non-invasive alternative to catheter-based surgery
20.01.2017 | GSI Helmholtzzentrum für Schwerionenforschung GmbH
Seeking structure with metagenome sequences
20.01.2017 | DOE/Joint Genome Institute
19.01.2017 | Event News
10.01.2017 | Event News
09.01.2017 | Event News
20.01.2017 | Awards Funding
20.01.2017 | Materials Sciences
20.01.2017 | Life Sciences